Abstract
Comorbidities Predict Inferior Survival in Patients Receiving CAR T-Cell Therapy for Relapsed/Refractory DLBCL: A Multicenter Retrospective Analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have